13.2K subscribers
3 photos
1 video
53.3K links
🔮Science Updates Daily!
🔮Every post with Source Link!
🔮This is 24/7 Working Channel!
🔮Each post is shared from Renowned Websites!

Buy ads: https://telega.io/c/Science_News_Facts_Updates_daily

admin : @The_Lawliet
Download Telegram
Vitamin D supplementation improves metabolic parameters in PCOS

Read Full Article

#VitaminD #PCOS #MetabolicHealth #Supplementation #HealthBenefits
❤2
Science News
Polycystic ovary syndrome (PCOS), a condition affecting more than 170 million people worldwide, has been officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a landmark global consensus study published today in The Lancet. Read Full…
⚪️ Polycystic ovary syndrome (PCOS) has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following a global study in The Lancet. The new name reflects its multisystem nature, impacting endocrine, metabolic, reproductive, dermatological, and psychological health.

⚪️ The previous name was inaccurate as many patients don't have ovarian cysts, leading to delayed diagnoses, fragmented care, stigma, and missed early interventions for metabolic and cardiovascular risks.

⚪️ PMOS emphasizes the condition's hormonal and metabolic complexity, acknowledges cardiometabolic effects, and still includes ovaries without overemphasizing reproductive issues, aiming for earlier diagnosis, holistic care, reduced fertility stigma, and expanded research.

#PCOS #HealthNews #MedicalUpdate
❤2
Researchers have published a proof-of-concept study demonstrating that injectable semaglutide may offer meaningful reproductive benefits for women with polyendocrine metabolic ovarian syndrome, (PMOS) formerly known as PCOS

Read Full Article

#PCOS #Semaglutide #ReproductiveHealth
Science News
Researchers have published a proof-of-concept study demonstrating that injectable semaglutide may offer meaningful reproductive benefits for women with polyendocrine metabolic ovarian syndrome, (PMOS) formerly known as PCOS Read Full Article #PCOS #Semaglutide…
✨ New study from CU Anschutz suggests injectable semaglutide may offer significant reproductive benefits for women with PMOS (formerly PCOS), addressing both fertility and metabolic health.

⚖️ Early findings in the RESTORE clinical trial indicate semaglutide could improve irregular cycles and elevated testosterone, particularly in those achieving 10% body weight loss.

🚀 Researchers are hopeful semaglutide can offer a more comprehensive treatment, tackling reproductive symptoms and metabolic dysfunction simultaneously, a challenge with current therapies.

#PCOS #Semaglutide #WomensHealth